Skip to main content
Tech.euFundingExplorerBeta

Xyall

A medtech innovator in molecular pathology

Total raised
€14M
€13,600,000
Funding rounds
2
Investors
7
distinct backers
Active since
2022-05
latest 2026-02

Funding by year

EUR raised per year · 2026 YTD

Signals

High confidence
Raise-next likelihood23
base rate 30% for Other
  • Raised very recently
  • Up-round momentum
Exit likelihood12
base rate 12% (2+ rounds)

    Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

    Similar companies

    same sector or country